ACE and acute respiratory distress syndrome: Patients with increased ACE activity were shown to have a higher risk of ARDS, whereas overexpression of ACE2 has a protective effect, and ACE2-/- mice have a more severe course of ARDS that responds to recombinant ACE2 administration.